Form 4 holding
General Counsel & Executive VP
QSAM Biosciences, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 02 May 2024
- Price
- $3.00
- Ownership
- Direct
Christopher M. Nelson
Insider Reports History
- Reporting-owner location
- Palm Beach, FL
- Latest reporting-owner signature
-
/s/ Christopher Nelson
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Christopher M. Nelson
Form 4 holding
General Counsel & Executive VP
QSAM Biosciences, Inc.
- Security class
- Series B
- Shares / value
- 4,557
- Estimated value
- Report date
- 23 Jun 2023
- Price
- Ownership
- Direct
Form 4 holding
General Counsel & Executive VP
QSAM Biosciences, Inc.
- Security class
- Options to buy common stock
- Shares / value
- 255
- Estimated value
- Report date
- 06 Feb 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 255
Form 4 holding
General Counsel & Executive VP
QSAM Biosciences, Inc.
- Security class
- Series B Convertible Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Feb 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Christopher M. Nelson
4
QSAM Biosciences, Inc.
- Report period
- 02 May 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 02 May 2024, 10:32
- Role
- General Counsel & Executive VP
- Next action
- Open filing details
4/A
QSAM Biosciences, Inc.
- Report period
- 06 Feb 2024
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 14 Feb 2024, 16:43
- Role
- EVP Corp Dev & General Counsel
- Next action
- Open filing details
4
QSAM Biosciences, Inc.
- Report period
- 06 Feb 2024
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 13 Feb 2024, 16:00
- Role
- EVP Corp Dev & General Counsel
- Next action
- Open filing details
4
QSAM Biosciences, Inc.
- Report period
- 23 Jun 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 23 Jun 2023, 16:30
- Role
- EVP Corp Dev & General Counsel
- Next action
- Open filing details
4
QSAM Biosciences, Inc.
- Report period
- 31 Dec 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 04 Jan 2023, 16:11
- Role
- General Counsel
- Next action
- Open filing details
4
QSAM Biosciences, Inc.
- Report period
- 03 Mar 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 07 Mar 2022, 19:02
- Role
- General Counsel
- Next action
- Open filing details
5
QSAM Biosciences, Inc.
- Report period
- 31 Dec 2021
- Transactions
- 6
- Transaction value
- +$400,000
- Accepted by SEC
- 14 Feb 2022, 20:58
- Role
- General Counsel and Director, Director
- Next action
- Open filing details